Pfizer Stock Gains After Earnings Beat. Revenue and Outlook Aren’t So Good.
Author
Tags
- Amgen,
- AMGN,
- Biopharmaceuticals,
- Biotech and Pharma,
- Biotechnology Services,
- breaking,
- C&E Industry News Filter,
- Content Types,
- corporate,
- Corporate/Industrial News,
- Earnings,
- Earnings Preview,
- Earnings Report,
- Factiva Filters,
- Financial Performance,
- GSK,
- GSK.LN,
- Healthcare,
- Healthcare/Life Sciences,
- Horizon Therapeutics,
- HZNP,
- industrial news,
- life sciences,
- Pharmaceuticals,
- Retail,
- Retail/Wholesale,
- S&P 500,
- S&P 500 Index,
- S&P 500 Pharmaceuticals,
- S&P 500 Pharmaceuticals Industry Index,
- Seagen,
- SGEN,
- SPX,
- synd,
- wholesale,
- Wholesalers,
- XX:SP500.352020